Using MRI neuroimaging, researchers develop a new method of quantifying brain tissue volume. The new method could provide an additional way to track the progress of multiple sclerosis and other neurological diseases.
Researchers have developed a new MRI neuroimaging technique which detects brain lesions associated with multiple sclerosis in finer detail than ever before. The technique could be a powerful tool for evaluating new treatment options for the disease.
A new study suggests that blood may hold clues to whether post-menopausal women may have an increased risk for brain damage that can lead to memory problems and an increased risk of stroke.
A new study found soldiers returning from Iraq and Afghanistan with mild TBI have measurable abnormalities in white matter when compared to returning veterans who have not experienced TBI. These abnormalities appear to be related to the severity of the injury and are related to cognitive deficits.
A new study has identified the two areas of the brain responsible for our perception of orientation and shape. Research found that the two neighbouring areas, known as human visual field maps, process the different types of visual information independently.
Scientists report researchers are now on the threshold of human application of stem cell therapies for a class of neurological diseases known as myelin disorders – a long list of diseases that include conditions such as multiple sclerosis, white matter stroke, cerebral palsy, certain dementias, and rare but fatal childhood disorders called pediatric leukodystrophies.
Using several neuroimaging methods, a team of researchers working at the University of Western Ontario have now uncovered that functional changes within a key brain network occur directly after a 30-minute session of noninvasive, neural-based training.
A European team of scientists have built the first atlas of white-matter microstructure in the human brain.
An inexpensive, five-minute eye scan can accurately assess the amount of brain damage in people with the debilitating autoimmune disorder multiple sclerosis (MS), and offer clues about how quickly the disease is progressing.